Latest topics referred to NICE: January 2012
Department of Health ministers agreed to refer the following topics to the National Institute for Health and Clinical Excellence (NICE) in January, to begin the process of developing guidance for each topic.
Public health
The following public health topics have been referred to NICE.
- Guidance for dental health practitioners on effective approaches to promoting positive oral health behaviour, including a positive patient experience of attendance at the dentist and reducing any anxiety among ‘dental phobics’. This would include content and modes of communication of dental health messages for the public.
- Guidance for local authorities on needs assessment and commissioning of community dental health programmes to promote the oral health of their communities, particularly vulnerable groups at risk of poor dental health. Epidemiological surveys would contribute to needs assessment.
- Guidance for carers working in health and social residential care settings (including nursing homes and residential care homes) on effective approaches to promoting oral health, preventing dental health problems and ensuring access to dental treatment when required .
Find out more about NICE public health guidance on the NICE website.
Quality standards
The following quality standards have been referred to NICE.
- Acute upper GI bleeding
- Autism (adults)
- Caesarean section
- Fertility
- Hypertension in pregnancy
- Lower urinary tract symptoms
- Multiple pregnancy
- Pain and bleeding in early pregnancy
- Rheumatoid arthritis
- Self harm
Read about NICE quality standards on the NICE website.
Clinical guidelines
The following clinical guidelines have been referred to NICE.
- Diagnosis and management of acute heart failure
- Diagnosis and management of bladder cancer
- Investigation and management of gastro-oesophageal reflux in children
- Diagnosis and management of drug allergy
- Diagnosis and management of pneumonia (including community acquired pneumonia)
Read about NICE clinical guidelines on the NICE website.
Technology appraisals
The following technology appraisals have been referred to NICE.
- To appraise the clinical and cost effectiveness of aflibercept in combination with irinotecan and fluorouracil-based therapy within its licensed indication for the treatment of metastatic colorectal cancer which has progressed following prior oxaliplatin-based chemotherapy.
- To appraise the clinical and cost effectiveness of aflibercept solution for injection, within its licensed indication, for the first-line treatment of wet age-related macular degeneration.
- To appraise the clinical and cost effectiveness of axitinib, within its licensed indication, for the treatment of advanced renal cell carcinoma after failure of prior systemic treatment.
- To appraise the clinical and cost effectiveness of pegloticase within its licensed indication for the treatment of hyperuricaemia in people with symptomatic gout whose disease is refractory to conventional urate-lowering therapy, or in whom conventional urate-lowering therapy is contraindicated or not tolerated.
- To appraise the clinical and cost effectiveness of pemetrexed, within its licensed indication, for maintenance treatment of non-squamous non-small-cell lung cancer for people whose disease has not progressed following induction therapy with pemetrexed and cisplatin.
- To appraise the clinical and cost effectiveness of ruxolitinib within its licensed indication for the treatment of myelofibrosis.
- To appraise the clinical and cost effectiveness of dapagliflozin within its licensed indication for the treatment of type 2 diabetes.
Find out more about NICE technology appraisals on the NICE website.
About NICE referrals
NICE is an independent organisation responsible for providing national guidance on promoting good health and preventing and treating ill health.
Department of Health ministers refer topics to NICE and NICE schedules these topics into its work programme, to begin the process of developing guidance for each topic.
Depending on the type of guidance and its complexity, this can take between 6 months and 2 years.
NICE guidance includes technology appraisals, clinical guidelines, public health guidelines and quality standards.
Find out more about NICE guidance on the NICE website.